濮阳东方地址濮阳东方医院男科治早泄评价好专业,濮阳东方男科医院割包皮手术便宜吗,濮阳东方妇科医院做人流多少钱,濮阳东方医院男科价格偏低,濮阳东方医院看妇科值得选择,濮阳东方妇科医院做人流手术很靠谱,濮阳东方男科医院割包皮手术安全不

BEIJING, March 3 (Xinhuanet) -- A new study suggested that regular use of painkiller ibuprofen may cut the risk of developing Parkinson's disease, according to Reuters reports.The research findings were published in the online edition of the journal Neurology on Wednesday and later will appear in the print edition on March 8.The study, which followed more than 136,000 U.S. men and women for six years, showed that people who took ibuprofen at least twice a week were 38 percent less likely to develop Parkinson's, a brain disorder that causes tremors and movement problems, compared to those who didn't take the pain reliever so often.Ibuprofen is sold in the U.S. as a non-steroidal anti-inflammatory drug (NSAID). But the study didn't prove that other NSAIDS, like aspirin or naproxen, could also cut the Parkinson's risk."Our study suggests ibuprofen could be a potential neuroprotective agent against Parkinson's," says lead researcher Dr. Xiang Gao from Harvard Medical School, "Protective effects are seen after taking ibuprofen two or more times a week. That's so-called regular use."However, he also warned that no proof has been found that ibuprofen itself can help ward off Parkinson's, and said that it's too early to recommend people to start taking ibuprofen to protect against the disorder.Gao said, "We just see an association, not some causal relationship."Besides, regular ibuprofen use has risks, like stomach bleeding and kidney damage.

BEIJING, May 16 (Xinhuanet) -- NASA has readied the space shuttle Endeavour for its liftoff set for Monday, media reported Monday.Good weather looks 70 percent likely for Monday's scheduled launch of Endeavour, the next-to-last U.S. space shuttle mission as NASA develops a new generation of craft for longer voyages."The updated forecast Sunday for Monday's launch of the shuttle Endeavour remains unchanged with a 70 percent chance of good weather," said NASA spokesman Allard Beutel.The space shuttle Endeavour STS-134 sits on launch pad 39A after the rollback of the Rotating Service Structure at the Kennedy Space Center in Cape Canaveral, Florida May 15, 2011.Liftoff is set for 8:56 a.m. EDT (1256 GMT) from the Kennedy Space Center for the trip to the International Space Station after the U.S. space agency repaired a technical glitch that canceled last month's launch attempt.The initial April 29 launch attempt was scrubbed hours before liftoff when technicians discovered a power failure in a heating line that served to prevent fuel from freezing in orbit.The six-member crew of astronauts including five Americans and one Italian, Roberto Vittori, will deliver a potent physics experiment to probe the origins of the universe during the mission, which will include four spacewalks.The 16-day mission is intended to help get the space station ready for operations after the shuttle fleet is retired. The 135th and final shuttle launch is scheduled for early- to mid-July aboard Atlantis.

BEIJING, Jan. 31 (Xinhua) -- Chinese Vice Premier Wang Qishan met in Beijing Monday with a delegation from the Geneva Association (GA), an insurance economics group, headed by chairman Nikolaus Von Bomhard.Wang hoped the GA board would hold a successful board meeting in Beijing, praising the positive role the organization played in promoting reform of the international insurance industry.China's insurance industry was undergoing rapid and profound changes and development, said Wang. He hoped the GA could work with Chinese insurance companies to jointly push forward the global development of the industry.Chinese Vice Premier Wang Qishan (R) meets with Nikolaus Von Bomhard, chairman of the Geneva Association (GA), an insurance economics group, in Beijing, capital of China, Jan. 31, 2011.Von Bomhard pledged the GA's commitment to stepping up exchanges and cooperation with the Chinese insurance sector.The Geneva Association describes itself as an international insurance "think tank" for strategically important insurance and risk management issues. It is the first time that the association has hosted a board meeting in an Asian country.

SAN FRANCISCO, March 29 (Xinhua) -- Computer networking equipment giant Cisco Systems Inc. on Tuesday announced the intent to buy privately-held software company newScale Inc., in a move to complement and expand its offerings in cloud computing.Based in San Mateo in the U.S. state of California, newScale provides software that delivers a service catalog and self-service portal for information technology (IT) organizations to select and quickly deploy cloud services within their businesses.Founded in 1999, the company now has more than two million users worldwide, including 20 percent of the Fortune 50 companies, according to information posted on newScale's website."With the acquisition of newScale, Cisco will be able to accelerate the deployment of cloud services through a service catalog and self-service portal that allows customers to easily manage their IT infrastructures," Parvesh Sethi, Cisco's senior vice president, noted in a statement.Cisco said it expects to close the deal in the second half of its fiscal year 2011, without disclosing financial terms.

WASHINGTON, April 6 (Xinhua) -- U.S. researchers have discovered two genes in which variation affects intake of caffeine, the most widely consumed stimulant in the world, according to a report described Wednesday in the open-access journal PLoS Genetics.A team of investigators from the National Cancer Institute, Harvard School of Public Health, Brigham and Women's Hospital, and the University of North Carolina at Chapel Hill examined genetic variation across the entire genome of more than 47,000 individuals from the U.S.They found the genes -- CYP1A2, which has previously been implicated in the metabolism of caffeine, and AHR, involved in the regulation of CYP1A2, played roles in regulating intake of caffeine. Individuals with the highest-consumption genotype for either gene consumed 40 mg more caffeine than those with the lowest-consumption genotype, equivalent to the amount of one-third cup of caffeinated coffee, or one can of cola.Caffeine is implicated in numerous physiological and medical conditions; it affects sleep patterns, energy levels, mood, and mental and physical performance. The identification of genes that have an impact on daily consumption offers opportunities to better understand these conditions. Further exploration of the identified genetic variants may provide insight into the speed of caffeine metabolism, how long caffeine circulates in the blood, or how strong the physiological effects of consuming a given amount of caffeine are.